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Abstract 
Purpose: The aim of the present work was to determine the effect of particle size and type of diluents 
on critical concentration for the disintegration of tablet formulations containing a physical binary mixture 
of a superdisintegrant (croscarmellose sodium, CS) and a diluent.  
Methods: The diluents used in this study were microcrystalline cellulose (MCC), dibasic calcium 
phosphate (DCP) and pregelatinized starch (PGS). Each diluent was divided into 2 different size ranges 
(small and large size)) and further mixed with 0 - 100 % CS. The binary mixture was compressed at 
controlled pressure, and the disintegration time and physical characteristic of the tablets were 
evaluated. 
Results: The point of CS concentration that markedly affected the disintegration time of the tablets was 
recorded as the critical concentration for disintegration. The results showed that the particle size of the 
diluent did not affect the disintegration time. The critical CS concentrations were 2 % for DCP and MCC 
tablets and 5 % for PGS tablet. Adding a small amount of CS improved the disintegration of the tablets. 
However, increasing the amount of CS in the formulation also affected the hardness of the tablets. The 
particle size of diluents had a significant effect on the critical concentration for tablet disintegration. 
Conclusion: Determining the type and appropriate amounts of diluent and disintegrant (percolating 
component) may be useful in the design of tablet formulations. 
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Drug delivery via oral route is the most preferable 
and convenient route of drug administration for 
both solid and liquid dosage forms [1,2]. Solid 
dosage forms especially tablets are widely used 
due to various advantages such as ease of 
administration, accurate dosage, self-medication, 
excellent physical and chemical stability, pain 
avoidance, and great patient compliance [3-5]. 
Medication tablets usually contain active 
pharmaceutical ingredients (APIs) and other 
excipients. In fact, excipients are vastly important 
in the development of the tablet dosage form 
because they have an effect on functionality and 
performance of tablets [6]. Various types of 
excipients have been employed in tablet 
formulations; for example, disintegrants, fillers, 
glidants, lubricants, etc. [7]. Among the tablet 
excipients, disintegrants are believed to be the 
essential one as they facilitate disintegration of 
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the tablet into smaller pieces, and promote drug 
dissolution and absorption [6,8].  
 
The percolation theory scrutinizes the critical 
points or percolation thresholds of the system, 
which one ingredient of the system emerges a 
geometrical phase transition, creating the 
connection with the entire system. The 
formulation features such as the percentage of 
drug released, release rate or mechanical 
properties often exhibit sudden changes at the 
point of percolation thresholds [9,10]. In fact, 
percolation theory is on the basis of generating of 
clusters. A cluster can be described as a group 
of the neighbor-occupied point in a network [11-
12]. It is considered as infinite or percolating 
cluster after this cluster spreads from one side to 
the other sides of the network. The concentration 
of a component that causes a maximum 
probability of appearance of a cluster of this 
component is named percolation threshold [13-
14]. In terms of solid dosage form design, the 
critical concentration of disintegrant or 
percolation threshold of disintegrant is required 
to achieve the minimum disintegration time. 
Determination of the critical concentration of 
disintegrant is an important parameter for 
designing of a tablet formulation [15-18].  
 
Therefore, the present study investigates the 
effect of size and type of diluents on critical 
concentration for the disintegration of tablets 
containing a physical binary mixture of a 
superdisintegrant (croscarmellose sodium) and a 
diluent. The critical concentration for 
disintegration was determined from disintegration 
time and disintegrant concentration profiles. 
MCC, DCP and PGS were used as diluents 
which represent different characteristics in term 
of water solubility and tablet deformation. 
Moreover, the tensile strength and hardness 
were also recorded in this study as a physical 




Microcrystalline cellulose (Avicel PH 102®; 
MCC) was purchased from FMC Corporation, 
USA. Dibasic calcium phosphate (DCP) was 
obtained from Budenheim, Germany. 
Croscarmellose sodium (CS) was purchased 
from CP drug center Co., Ltd., Thailand. 
Magnesium stearate (Mgst) was purchased from 
Glaxo welcome, UK. Pre-gelatinized starch 




In order to determine the effect of particle size of 
diluents on critical concentration for 
disintegration of tablets, the diluents (MCC, DCP) 
were sieved and separated into two different 
sizes using a vibratory sieve shaker (Haan W®, 
Germany Model vibro Serial No. 67406). The 
diluents and disintegrants were kept at 50 ºC in 
hot-air oven for 2 h and kept in tight container 
until used. 
 
Preparation of formulations 
 
Different binary mixtures composed of a direct 
compression diluent and a disintegrant were 
chosen as model mixtures. For each diluent-
disintegrant model, different preparations with 
increasing disintegrant volume ratio (0, 2, 5, 10, 
15, 20, 25, 30, 40, 50, 60, 70, 80, 90 and 100 %) 
were mixed for 15 min and stored in a dessicator 
with silica gel for 12 h prior to tableting.  
 
Preparation of tablet 
 
For each of binary mixture, the mixtures were 
directly compressed on a well-polished stainless 
steel punch and die assembly (9.0 mm) in a 
hydraulic press (Model SPCAC 15011) at a 
pressure of 5 kD to obtain the round, flat, 9 mm 
diameter tablets.  
 
Characterization of tablets 
 
Weight, diameter and thickness 
 
As a physical description and record of the tablet 
quality, the weight, diameter and thickness of the 
tablets compressed from the binary mixtures of 
the diluents and CS were recorded. The weight 
of 20 tablets corresponding to each formulation 
was determined using an analytical balance 
(Satorius® aggottingen, Germany, Model 
CP224S) to assure the weight uniformity. 
Thickness and diameter of 10 tablets of each 
formulation were measured using a 25-mm 
digital micrometer (Comecta, SA). 
 
Compact tensile strength  
  
The compact crushing strength of each 
formulation was determined using a Hardness 
tester (ERWEKA® GmbH, Germany, Model 
TBH225TD). The effect of CS in the binary 
mixtures on the hardness of the tablets was also 




Disintegration studies on 6 tablets of each 
formulation were performed using a disintegrator 
(ERWEKA® GmbH, Germany, Model ZT323) 
without discs. The test was conducted in distilled 
water at 37 ± 2 °C. 
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Statistical analysis  
 
The data were analyzed using SPSS software. 
Statistical significance of differences between 
formulations in each experiment was examined 
using independent t-test. The differences were 




Weight, diameter and thickness 
 
The weight, diameter and thickness of the tablets 
compressed from the binary mixtures of the 
diluents and CS were recorded as a physical 
description and record of the tablet quality (data 
not shown) 
 
Particle size of the diluents 
 
Prior to the binary-mixture preparation, the 
diluents (MCC, DCP and PGS) were sieved and 
the sizes were determined. MCC, DCP and PGS 
were separated into two different sizes to 
determine the effect of particle size of diluent on 
critical concentration for the disintegration of 
tablets. The small and larger sizes of MCC used 
to prepare the binary mixtures were about 112.5 
and 215.0 µm, respectively. On the other hand, 
the small and larger sizes of DCP employed to 
prepare the binary mixtures were approximately 
215.0 and 337.5 µm, respectively. Finally, the 
small and larger sizes of PGS used were 
recorded to be and less than 112.5 and112.5 
µm, respectively. 
 
Tablet disintegration  
 
In this study, the effect of different types and 
sizes of the diluents used on the disintegration 
time of the tablets containing CS as a 
disintegrant was investigated. The critical 
concentration for disintegration or percolation 
thresholds (Cp) describes the amount of 
disintegrant used in the tablet formulation that 
expresses the minimum value of the 
disintegration time. Figure 1 displays the 
relationship between the amount of CS in the 
binary mixture before tableting and the 
disintegration time of the tablets containing MCC. 
As it can be seen from the graph, in the case of 
the binary mixtures of MCC and CS, the amount 
of CS used at 2 % v/v was efficient enough to 
trigger a very fast disintegration. Interestingly, 
increasing the amount of CS in the formulations 
led to delay the disintegration. However, the 
formulations containing CS exhibited significantly 
lesser disintegration time as compared to the 
formulation without CS. Therefore, the Cp of the 
CS in the formulations was observed to be 2 % 
v/v. Using whether small size MCC or large size 
MCC offered the similar pattern of disintegration 
(Figure 1a and b). The tablets containing small 
size MCC demonstrated significantly faster 
disintegration as compared with those containing 
big size MCC at the CS amount of 15-90 %. 
 
The formulations containing DCP and CS 
presented the similar findings to those of MCC 
and CS. Figure 2 shows the relationship between 
the amount of CS in the binary mixture before 
tableting and the disintegration time of the tablets 
containing DCP. The percolation threshold (Cp) 
of the CS in the formulations was witnessed to 
be 2 % v/v as well, and the amount of CS in the 
formulation affected the disintegration time. 
Increasing amount of CS resulted in the increase 
in disintegration time. In addition, no 
disintegration has been observed in the tablets 
containing only DCP after 1 h. The particle sizes 
of DCP have a significant effect on the 
disintegration time (Figure 2a and Figure 2b). In 
the formulations with 15 - 20 and 50 % CS, the 
tablets containing small size DCP exhibited 
faster disintegration than those containing big 
size DCP. However, at the greater amount of CS  
 
Figure 1: The relationship between the amount of CS in the binary mixture before tableting and the disintegration 
time of the tablets containing MCC: (a) small size MCC (112.5 µm) (b) bigger size MCC (215.0 µm). *Statistical 
difference in the disintegration of tablets containing (a) small particle size MCC and (b) large particle size MCC at 
similar CS ratio 
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Figure 2: Relationship between the amount of CS in the binary mixture before tableting and the disintegration 
time of the tablets containing DCP: (a) small size DCP (215.0 µm) (b) bigger size DCP (337.5 µm). *Statistical 
difference in the disintegration of tablets containing (a) small particle size DCP and (b) large particle size DCP at 
the similar CS ratio 
 
 
Figure 3: Relationship between the amount of CS in the binary mixture before tableting and the disintegration 
time of the tablets containing PGS: (a) small particle size PGS (< 112.5 µm) (b) larger particle size PGS (112.5 
µm). *Statistical difference in the disintegration of tablets containing (a) small size PGS and (b) big size PGS at 
the similar CS ratio 
 
(90 %) in the formulation, the tablets containing 
big size DCP demonstrated faster disintegration 
than those containing small size DCP. 
 
The disintegration study of the formulation 
comprising PGS and CS was also assessed. The 
percolation threshold (Cp) of the CS in the 
formulations was 5 % v/v (Figure 3). The higher 
amount of CS in the formulation led to the faster 
disintegration of the tablets. No disintegration 
has been noticed in the tablets containing only 
PGS. The bigger particle size of PGS led to the 
significantly faster disintegration of the tablets 
formulation containing 0 - 90 % CS as presented 
in Figure 3a and Figure 3b. 
 
Tablet hardness  
 
Hardness is one of the important factors that 
have an effect on disintegration time of tablets. 
This study also investigated the effect of the 
amount of CS in the formulations on the 
hardness of the tablets. For the tablets 
containing MCC, the increase in CS amount from 
2 to 10 % in the formulations have an only small 
effect on the hardness of the tablets. Further 
increased the CS in the formulation (> 10 %) 
resulted in the decrease in hardness of the 
tablets. The small size MCC have more effect on 
the decrease in hardness as compared to the 
bigger size MCC does as shown in Figure 4. The 
significant difference in the hardness of the 
tablets containing small size and big size MCC 
was found at 0 – 5 and 15 – 90 % CS in the 
formulations. 
 
In the case of the formulation containing DCP 
and CS, the hardness gradually increased with 
an increase in CS amount. The addition of CS 
more than 40 % into the formulation led to the 
dramatic increase in the hardness. The hardness 
of the formulations containing small particle size 
DCP was significantly greater than that of the 
formulations containing big particle size DCP. 
However, when the formulations consisted of the 
high amount of CS (80-90 %), the hardness of 
the formulations containing big particle size DCP 
was significantly greater than that of the 
formulations containing small particle size DCP 
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Figure 4: Relationship between the amount of CS in the binary mixture before tableting and the hardness of the 
tablets containing MCC: (a) small size MCC (112.5 µm) (b) bigger size MCC (215.0 µm). *Statistical difference in 
the hardness of tablets containing (a) small size MCC and (b) big size MCC at the similar CS ratio 
 
Figure 5: Relationship between the amount of CS in the binary mixture before tableting and the hardness of the 
tablets containing DCP: (a) small particle size DCP (215.0 µm) (b) bigger size DCP (337.5 µm). *Statistical 
difference in the hardness of tablets containing (a) small size DCP and (b) big size DCP at the similar CS ratio
 
Figure 6: Relationship between the amount of CS in the binary mixture before tableting and the hardness of the 
tablets containing MCC: (a) small particle size PGS (< 112.5 µm) (b) larger particle size PGS (112.5 µm). 
*Statistical difference in the hardness of tablets containing (a) small size PGS and (b) big size PGS at the similar 
CS ratio 
 
On the other hand, in the formulation containing 
PGS and CS, increasing the amount of CS in the 
formulation caused a fluctuating change in the 
hardness. The hardness seemed to decrease 
after increased the amount of CS in the 
formulations containing small size PGS.  
However, in the formulation containing big size 
PGS, the hardness increased as the amount of 
CS in the formulations increased. The tablets 
containing small size PGS exhibited significantly 
higher and more fluctuate hardness as compared 




Percolation theory has been employed in 
pharmaceutical industry to improve tablet 
formulation and production processes. In order to 
design tablet formulations, the dissolution and 
disintegration of the tablets need to be taken into 
account. The disintegration of tablets remains an 
important issue for the desirable release of the 
active pharmaceutical ingredient from a solid 
dosage formulation [19]. It has been reported 
that heterogeneous mixtures like pharmaceutical 
formulations for solid dosage forms demonstrate 
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disarranged particulate systems where it is 
necessary to consider a geometrical 
representation, in other words, a topological 
modeling [17,20]. Geometrical phase transitions 
are independent of physical and chemical 
properties of the components, which enable the 
modeling. Actually, percolation theory is the most 
suitable model to predict and simulate the 
geometrical phase transitions in a complex multi-
particulate system [21,22]. As stated by 
percolation theory, a transitional change 
occurred at a critical concentration of 
components in a system when one component 
forms a cluster spreading throughout the whole 
system. This critical concentration, known as 
percolation threshold (Cp), is assigned to the 
volumetric ratio (% v/v) of the percolating 
component [13,14].  
 
In this study, CS was used as a disintegrant, and 
MCC, DCP and PGS were used as diluents. As a 
matter of fact, MCC represents the water-soluble 
diluents which can help in disintegration process 
and demonstrates plastic deformation. On the 
other hand, DCP stands for the water-insoluble 
diluents which demonstrate fragmentation 
deformation. In addition, PGS represents the 
diluents that have been modified to improve 
water solubility and displayed an elastic 
deformation. In the theoretical point of views, CS 
acts as the percolating component that was 
expected to penetrate through the diluent and 
form an infinite cluster network structure 
spreading in the particulate system. Increasing 
the amount of the CS in the mixture could lead to 
the destruction of the network structure of the 
diluents and generate the new network.  
 
The results from the disintegration study of the 
tablet formulation containing CS revealed that 
just little amount of CS can improve the 
disintegration of the tablets. In the formulation of 
MCC and CS, or DCP and CS, the percolation 
threshold was similar and found to be very low as 
2 % v/v even through MCC and DCP are 
different in water solubility. In fact, CS is a 
superdisintegrant that can destroy the network 
structure of the diluent and reduce the attraction 
force between the diluent molecules resulted in 
the disintegration of the tablets. When the tablets 
contact with water, water will penetrate into the 
tablets. This can cause the CS to swell and lead 
to the disintegration of the tablets. In the case of 
PGS, the percolation threshold was found to be 5 
% v/v. This is because PGS formed gels after 
contacted with water and decelerate the 
penetration of water into the tablets. Therefore, a 
higher amount of the disintegrant is necessary to 
induce disintegration. The effect of diluent sizes 
on the disintegration properties was also 
investigated. The results showed that the size of 
the diluents has an effect on disintegration. The 
tablet formulations containing small particle size 
MCC demonstrated faster disintegration 
compared with the formulation containing large 
particle size MCC. This may be due to the 
swelling properties of MCC. The small size MCC 
could swell faster and results in the faster 
disintegration. In the formulation containing PGS 
and CS, bigger particle size of PGS led to the 
faster disintegration. This may be because the 
tablets prepared from bigger PGS could be more 
porous than those prepared from small size 
PGS. The small particle size PGS might fill in the 
space between particles and then hinders the 
water penetration into the tablets when contact 
with water.    
 
As expected, when CS demonstrates elastic 
deformation, it would destroy the network 
structure of the diluent and generate the new 
network between CS and the diluent. This leads 
to the change in hardness of the tablets after 
increasing the amount of CS in the formulations. 
There are some differences in hardness in the 
formulation containing different diluents after 
increasing the amount of CS in the formulation. 
This may be due to the different in deformation 




The critical concentration for disintegration or 
percolation thresholds (Cp) is the amount of 
disintegrant used in the tablet formulation to 
obtain the minimum value of the disintegration 
time. The amount of CS used at 2 % v/v is 
sufficient to initiate rapid disintegration of the 
tablets prepared from MCC and CS mixture as 
well as DCP/CS mixture. A greater amount of CS 
(5 %) is needed for the disintegration of the 
tablets prepared from PGS and CS mixture. The 
particle size of the diluents has an effect on the 
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